Bausch Health approves share buyback program
Published
The Board of Directors of Canadian pharmaceutical company Bausch Health Companies Inc. approved a share buyback program on October 28, 2026. The announcement was published by financial data provider MarketScreener.
In a share buyback program, a company repurchases its own shares on the market. This reduces the number of shares in circulation. Companies often use such programs to return surplus capital to their shareholders or to support the price of their shares.
However, important details are missing from this announcement. It does not state how many shares are to be repurchased, what the total volume of the program is, or how long it will run. There is also no further information about the reasons behind the Board's decision.
The news primarily concerns investors who hold the company's shares. A direct significance for the German market or for consumers in Germany is not apparent from the available information. Further details about the program are likely to be published in the company's documents or in later reports.
Sources: MarketScreener Deutschland
More Germany news
- Mercedes-Benz Halts Investment in German Plants and Weighs Closures
- Housing Benefit Cut Dropped: 1.3 Million Households Keep Wohngeld
- Align Technology unveils new innovations for Invisalign treatment
- Large Solar Park in Merbitz Feeds Electricity into the Grid
- Nvidia shares fall sharply: How safe is pension money?
- Telekom baut Rechenzentrum für Industrie und KI aus
- Autonomous Buses to Enter Everyday Life: TUM Leads New DZM Site
- Cigarettes from the EU Abroad: Duty-Free Allowance Not Dropping for Now